Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04773834 · ClinicalTrials.gov registry record · NA
Evaluation of an Automated Physician-Directed Messaging on Patient Engagement in the Digital Diabetes Prevention Program
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 551
- Enrollment target
NCT04773834 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 551 participants.
The verdict
NCT04773834, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 551 participants
- Enrollment target
Study Summary
This study aims to understand the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program (dDPP). The messages are tailored to patient engagement levels based on established engagement thresholds, which are based on the patient's use of the dDPP application. The system is designed to minimize work for providers by sending automated targeted messages to patients to potentially increase engagement, prevent onset of diabetes and improve clinical outcomes. The patients in the study are automatically nudged using a combination of text messaging and MyChart messaging.
Interventions
- OTHER Digital diabetes prevention program (dDPP)
- OTHER Adapted dDPP-EHR tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04773834
The ClinicalTrials.gov registry entry for NCT04773834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 551 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Digital diabetes prevention program (dDPP) is the first listed.
NCT04773834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04773834 about?
NCT04773834 is a clinical study titled "Evaluation of an Automated Physician-Directed Messaging on Patient Engagement in the Digital Diabetes Prevention Program". This study aims to understand the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program (dDPP). The messages are tailored to patient engagement levels based on established engagement thresholds, which are based on the patient's use of the ...
What is the current status of trial NCT04773834?
This trial is currently completed. It is a NA study. The enrollment target is 551 participants. The study started on 2021-02-01. Estimated completion is 2025-06-01.
What interventions are being tested in trial NCT04773834?
The interventions under investigation include: Digital diabetes prevention program (dDPP) (OTHER), Adapted dDPP-EHR tool (OTHER).
Who is sponsoring clinical trial NCT04773834?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.